跳至主導覽 跳至搜尋 跳過主要內容

A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling

研究成果: 雜誌貢獻 › 文章 › 同行評審

摘要

Bladder cancer therapy is frequently limited by inefficient drug retention and adaptive immune resistance within a hypoxic tumor microenvironment. Here, we report a CD44-targeted, fully synthetic nanocomposite (HPPZC) that converts chemotherapy into a mitochondria-associated therapeutic strategy accompanied by tumor immune remodeling. Rapid microwave-assisted assembly integrates hyaluronic acid (HA), polydopamine (PDA), protamine, zinc oxide (ZnO), and camptothecin (CPT) into a structurally integrated hybrid nanocomposite with tumor targeting, while the PDA/ZnO interface functions as a redox-active platform associated with mitochondrial dysfunction and redox modulation. HPPZC induces rapid mitochondrial depolarization, elevates oxidative stress, and is associated with PINK1/Parkin-related mitochondrial quality-control and autophagy-associated turnover signatures. In vivo, HPPZC treatment prolonged local intratumoral retention and produced tumor regression. The combination of chemotherapy with mitochondrial stress and tumor immune remodeling, suppressing CXCL12 and PD-L1, promoting M1-like marker profile, and increasing CD8⁺ T-cell infiltration. This work establishes a reproducibly fabricated redox-active nanotherapeutic associated with mitochondrial stress that couples targeted chemotherapy with immune microenvironment remodeling for antitumor efficacy.
原文英語
文章編號840
期刊Journal of Nanobiotechnology
卷24
發行號1
DOIs
出版狀態已發佈 - 12月 2026

UN SDG

此研究成果有助於以下永續發展目標

  1. SDG 3 - 良好的健康和福祉
    SDG 3 良好的健康和福祉

ASJC Scopus subject areas

  • 醫藥(雜項)
  • 生物工程
  • 應用微生物與生物技術
  • 分子醫學
  • 生物醫學工程
  • 藥學科學

指紋

深入研究「A CD44-targeted PDA/ZnO redox-active nanocomposite that couples chemotherapy with mitochondrial stress and tumor immune remodeling」主題。共同形成了獨特的指紋。

引用此